Insulin-like growth factor binding protein-5 (IGFBP-5) is an osteoblast sec
retory protein that becomes incorporated into the mineralized bone matrix.
In osteoblast cultures, IGFBP-5 stimulates cell proliferation by an IGF-ind
ependent mechanism. To evaluate whether IGFBP-5 can stimulate osteoblast ac
tivity and enhance bone accretion in a mouse model of osteoblast insufficie
ncy, daily subcutaneous injections of either intact [IGFBP-5 (intact)] or c
arboxy-truncated IGFBP-5 [IGFBP-5-(1-169)] were given to ovariectomized (OV
X) mice for 8 wk. Femur and spine bone mineral density (BMD), measured ever
y 2 wk, showed early and sustained increases in response to IGFBP-5. Bone h
istomorphometry of cancellous bone showed significant elevations in the bon
e formation rate in both the femur metaphysis [IGFBP-5(1-169)] only) and sp
ine compared with OVX controls. IGFBP-5 also stimulated osteoblast number i
n the femur IGFBP-5-( 1-169) only) and spine. These data indicate that IGFB
P-5 effectively enhances bone formation and bone accretion in OVX mice by s
timulating osteoblast activity. The finding that IGFBP-5-(1-169) is bioacti
ve in vivo indicates that the carboxy-terminal portion is not required for
this bone anabolic effect.